Zobrazeno 1 - 10
of 14
pro vyhledávání: '"McDermott MSJ"'
Autor:
O'Brien NA; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California., McDermott MSJ; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California., Zhang J; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California., Gong KW; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California., Lu M; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California., Hoffstrom B; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California., Luo T; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California., Ayala R; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California., Chau K; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California., Liang M; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California., Madrid AM; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California., Donahue TR; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Glaspy JA; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California., Presta L; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California., Slamon DJ; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2023 Dec 01; Vol. 22 (12), pp. 1365-1375.
Autor:
McDermott MSJ; Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland., Browne BC; Cancer Research Program, The Kinghorn Cancer Centre, Garvan Institute of Medical Research Sydney, Sydney, NSW, Australia., Conlon NT; Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland., O'Brien NA; Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA., Slamon DJ; Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA., Henry M; Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland., Meleady P; Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland., Clynes M; Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland., Dowling P; Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland.; Department of Biology, National University of Ireland, Maynooth, Maynooth, Co, Kildare, Ireland., Crown J; Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland.; Department of Medical Oncology, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland., O'Donovan N; Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland. Norma.ODonovan@dcu.ie.
Publikováno v:
Molecular cancer [Mol Cancer] 2023 Oct 30; Vol. 22 (1), pp. 175. Date of Electronic Publication: 2023 Oct 30.
Autor:
Gaynor N; Cancer Biotherapeutics Research Group, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland., Blanco A; Flow Cytometry Core Technology, UCD Conway Institute, University College Dublin, Dublin, Ireland., Madden SF; Data Science Centre, School of Population Heath Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland., Moran B; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland., Fletcher JM; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.; School of Medicine, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland., Kaukonen D; Data Science Centre, School of Population Heath Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland., Ramírez JS; Cancer Biotherapeutics Research Group, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland., Eustace AJ; School of Biotechnology, Dublin City University, Dublin, Ireland., McDermott MSJ; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland., Canonici A; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland., Toomey S; Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland., Teiserskiene A; Cancer Trials Ireland, RCSI House, 121 St. Stephen's Green, Dublin, Ireland., Hennessy BT; Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.; Cancer Trials Ireland, RCSI House, 121 St. Stephen's Green, Dublin, Ireland., O'Donovan N; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland., Crown J; Cancer Biotherapeutics Research Group, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland., Collins DM; Cancer Biotherapeutics Research Group, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland. denis.collins@dcu.ie.
Publikováno v:
British journal of cancer [Br J Cancer] 2023 Oct; Vol. 129 (6), pp. 1022-1031. Date of Electronic Publication: 2023 Jul 28.
Autor:
McDermott MSJ; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., O'Brien NA; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Hoffstrom B; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Gong K; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Lu M; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Zhang J; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Luo T; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Liang M; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Jia W; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Hong JJ; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Chau K; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Davenport S; Pathology, University of Southern California, Los Angeles, California., Xie B; Pathology, University of Southern California, Los Angeles, California., Press MF; Pathology, University of Southern California, Los Angeles, California., Panayiotou R; Department of Cell Biology and Ludwig Center at Harvard, Harvard Medical School, Boston, Massachusetts., Handly-Santana A; Department of Cell Biology and Ludwig Center at Harvard, Harvard Medical School, Boston, Massachusetts., Brugge JS; Department of Cell Biology and Ludwig Center at Harvard, Harvard Medical School, Boston, Massachusetts., Presta L; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Glaspy J; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Slamon DJ; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Jun 01; Vol. 29 (11), pp. 2131-2143.
Autor:
Ding X; Department of Drug Discovery and Biomedical Sciences, University of South Carolina College of Pharmacy, 715 Sumter St., Columbia, SC, 29208., Sharko AC; Department of Drug Discovery and Biomedical Sciences, University of South Carolina College of Pharmacy, 715 Sumter St., Columbia, SC, 29208., McDermott MSJ; Department of Drug Discovery and Biomedical Sciences, University of South Carolina College of Pharmacy, 715 Sumter St., Columbia, SC, 29208., Schools GP; Department of Drug Discovery and Biomedical Sciences, University of South Carolina College of Pharmacy, 715 Sumter St., Columbia, SC, 29208., Chumanevich A; Department of Drug Discovery and Biomedical Sciences, University of South Carolina College of Pharmacy, 715 Sumter St., Columbia, SC, 29208., Ji H; Department of Drug Discovery and Biomedical Sciences, University of South Carolina College of Pharmacy, 715 Sumter St., Columbia, SC, 29208., Li J; Department of Drug Discovery and Biomedical Sciences, University of South Carolina College of Pharmacy, 715 Sumter St., Columbia, SC, 29208., Zhang L; Department of Drug Discovery and Biomedical Sciences, University of South Carolina College of Pharmacy, 715 Sumter St., Columbia, SC, 29208., Mack ZT; Department of Drug Discovery and Biomedical Sciences, University of South Carolina College of Pharmacy, 715 Sumter St., Columbia, SC, 29208., Sikirzhytski V; Department of Drug Discovery and Biomedical Sciences, University of South Carolina College of Pharmacy, 715 Sumter St., Columbia, SC, 29208., Shtutman M; Department of Drug Discovery and Biomedical Sciences, University of South Carolina College of Pharmacy, 715 Sumter St., Columbia, SC, 29208., Ivers L; National Institute for Cellular Biotechnology, Dublin City University, Dublin 9, Ireland., O'Donovan N; National Institute for Cellular Biotechnology, Dublin City University, Dublin 9, Ireland., Crown J; National Institute for Cellular Biotechnology, Dublin City University, Dublin 9, Ireland., Győrffy B; Department of Bioinformatics, Semmelweis University, Budapest, H-1085, Hungary.; Oncology Biomarker Research Group, Research Center for Natural Sciences, H-1117, Budapest, Hungary., Chen M; Department of Drug Discovery and Biomedical Sciences, University of South Carolina College of Pharmacy, 715 Sumter St., Columbia, SC, 29208.; Senex Biotechnology, Inc., 715 Sumter St., Columbia, SC, 29208., Roninson IB; Department of Drug Discovery and Biomedical Sciences, University of South Carolina College of Pharmacy, 715 Sumter St., Columbia, SC, 29208., Broude EV; Department of Drug Discovery and Biomedical Sciences, University of South Carolina College of Pharmacy, 715 Sumter St., Columbia, SC, 29208.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2022 Aug 09; Vol. 119 (32), pp. e2201073119. Date of Electronic Publication: 2022 Aug 01.
Autor:
O'Brien NA; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California., Huang HKT; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California., McDermott MSJ; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California., Madrid AM; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California., Luo T; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California., Ayala R; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California., Issakhanian S; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California., Gong KW; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California., Lu M; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California., Zhang J; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California., Slamon DJ; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2022 May 04; Vol. 21 (5), pp. 751-761.
Autor:
Sharko AC; Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, SC 29208, USA., Lim CU; Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, SC 29208, USA., McDermott MSJ; Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, SC 29208, USA., Hennes C; Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, SC 29208, USA., Philavong KP; Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, SC 29208, USA., Aiken T; Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, SC 29208, USA., Tatarskiy VV; Institute of Gene Biology, Russian Academy of Sciences, 119334 Moscow, Russia., Roninson IB; Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, SC 29208, USA., Broude EV; Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, SC 29208, USA.
Publikováno v:
Cells [Cells] 2021 Jan 12; Vol. 10 (1). Date of Electronic Publication: 2021 Jan 12.
Autor:
O'Brien NA; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at UCLA, Los Angeles, CA, USA., McDermott MSJ; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Conklin D; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Luo T; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Ayala R; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Salgar S; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Chau K; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at UCLA, Los Angeles, CA, USA., DiTomaso E; Novartis Pharmaceuticals, Cambridge, MA, USA.; Currently Bayer Pharmaceuticals, Boston, MA, USA., Babbar N; Novartis Pharmaceuticals, Cambridge, MA, USA., Su F; Novartis Pharmaceuticals, Cambridge, MA, USA., Gaither A; Novartis Pharmaceuticals, Cambridge, MA, USA.; Currently LG Life Sciences, Cambridge, MA, USA., Hurvitz SA; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Linnartz R; Novartis Pharmaceuticals, Cambridge, MA, USA., Rose K; Novartis Pharmaceuticals, Cambridge, MA, USA., Hirawat S; Novartis Pharmaceuticals, Cambridge, MA, USA.; Currently Bristol Myers Squibb, Lawrenceville, NJ, USA., Slamon DJ; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at UCLA, Los Angeles, CA, USA. dslamon@mednet.ucla.edu.; UCLA Translational Oncology, 2825 Santa Monica Blvd, Suite 200, Santa Monica, CA, 90404, USA. dslamon@mednet.ucla.edu.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2020 Aug 14; Vol. 22 (1), pp. 89. Date of Electronic Publication: 2020 Aug 14.
Autor:
McDermott MSJ; Department of Drug Discovery and Biomedical Sciences, South Carolina College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA., Sharko AC; Department of Drug Discovery and Biomedical Sciences, South Carolina College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA., Munie J; Department of Drug Discovery and Biomedical Sciences, South Carolina College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA., Kassler S; Department of Drug Discovery and Biomedical Sciences, South Carolina College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA., Melendez T; Department of Drug Discovery and Biomedical Sciences, South Carolina College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA., Lim CU; Department of Drug Discovery and Biomedical Sciences, South Carolina College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA., Broude EV; Department of Drug Discovery and Biomedical Sciences, South Carolina College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA.
Publikováno v:
Cells [Cells] 2020 Mar 06; Vol. 9 (3). Date of Electronic Publication: 2020 Mar 06.
Autor:
McDermott MSJ; Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA. mmcdermott@mednet.ucla.edu.; Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, 9 Dublin, Ireland. mmcdermott@mednet.ucla.edu., Conlon N; Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, 9 Dublin, Ireland. neil.conlon@dcu.ie., Browne BC; Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, 9 Dublin, Ireland. brigid_browne@yahoo.com., Szabo A; Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, 9 Dublin, Ireland. adamkoszabo@gmail.com., Synnott NC; UCD School of Medicine and Medical Science, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, 4 Dublin, Ireland. naoisesynnott@gmail.com., O'Brien NA; Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA. NOBrien@mednet.ucla.edu., Duffy MJ; UCD School of Medicine and Medical Science, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, 4 Dublin, Ireland. michael.j.duffy@ucd.ie.; UCD Clinical Research Centre, St. Vincent's University Hospital, 4 Dublin, Ireland. michael.j.duffy@ucd.ie., Crown J; Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, 9 Dublin, Ireland. john.crown@cancertrials.ie.; Department of Medical Oncology, St. Vincent's University Hospital, Elm Park, 4 Dublin, Ireland. john.crown@cancertrials.ie., O'Donovan N; Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, 9 Dublin, Ireland. norma.odonovan@dcu.ie.
Publikováno v:
Cancers [Cancers (Basel)] 2019 Feb 08; Vol. 11 (2). Date of Electronic Publication: 2019 Feb 08.